| View |
|
DR-XY47840
|
Pioglitazone (as hydrochloride) + Metformin (as
hydrochloride)
|
Lodiglit
|
15 mg / 850 mg
|
Film Coated Tablet
|
Oral Hypoglycemic
|
Standard Chem. & Pharm. Co., Ltd. (Plant II)
|
Taiwan
|
Monitored Release
|
29 March 2022
|
29 March 2027
|
| View |
|
DR-XY47841
|
Oxytocin
|
Oxyt 10
|
10 IU/mL
|
Solution for Injection (IM/IV)
|
Posterior Pituitary Hormones
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
Renewal
|
28 April 2024
|
30 March 2029
|
| View |
|
DR-XY47842
|
Oxytocin
|
Oxyt 5
|
5 IU/ mL
|
Solution for Injection (IM/IV)
|
Posterior Pituitary Hormones
|
Steril-Gene Life Sciences (P) Ltd.
|
India
|
Renewal
|
25 April 2024
|
30 March 2029
|
| View |
|
DR-XY47843
|
Mupirocin (As Calcium Dihydrate)
|
Mucin
|
20 mg/g (2% w/w)
|
Cream
|
Antibacterial
|
Global Pharmaceuticals (Pvt.) Ltd.
|
Pakistan
|
Initial
|
30 March 2022
|
30 March 2027
|
| View |
|
DR-XY47844
|
Paclitaxel
|
Bravifo
|
6 mg / mL (30 mg / 5 mL)
|
Solution for Infusion
|
Antineoplastic Agent (Taxane)
|
MSN Laboratories Private Limited (Formulations
Division)
|
India
|
Initial
|
29 March 2022
|
29 March 2027
|
| View |
|
DR-XY47845
|
Paclitaxel
|
Bravifo
|
6 mg/mL (100 mg/16.7 mL)
|
Solution for Injection (IV
Infusion)
|
Antineoplastic Agent (Taxane)
|
MSN Laboratories Private Limited (Formulations Division)
|
India
|
Initial (Correction)
|
13 March 2023
|
29 March 2027
|
| View |
|
DR-XY47846
|
Paclitaxel
|
Bravifo
|
6 mg/mL (300mg/50mL)
|
Solution for Injection (IV
Infusion)
|
Antineoplastic Agent (Taxane)
|
MSN Laboratories Private Limited (Formulations Division)
|
India
|
Initial (Correction)
|
13 March 2023
|
29 March 2027
|
| View |
|
DR-XY47847
|
Darifenacin (As Hydrobromide)
|
Daritor-7.5
|
7.5 mg
|
Extended-Release Tablet
|
Urological
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial
|
29 March 2022
|
29 March 2027
|
| View |
|
DR-XY47848
|
Darifenacin (as Hydrobromide)
|
Daritor-15
|
15 mg
|
Extended-Release Tablet
|
Urological
|
Torrent Pharmaceuticals Ltd.
|
India
|
Initial
|
29 March 2022
|
29 March 2027
|
| View |
|
DR-XY47849
|
Ascorbic Acid + Bioflavonoids
|
Neutrabliss
|
1 g/50 mg
|
Tablet
|
Vitamins
|
Factors Group of Nutritional Companies Inc.
|
Canada
|
Initial
|
29 March 2022
|
29 March 2027
|
| View |
|
DR-XY47850
|
Methylprednisolone Sodium Succinate
|
Novestrol
|
125 mg/mL
|
Powder For Injection (IV/IM)
|
Corticosteroid
|
PT.Novell Pharmaceutical Laboratories
|
Indonesia
|
Initial
|
30 March 2022
|
30 March 2027
|
| View |
|
DR-XY47852
|
Methylprednisolone Sodium Succinate
|
Succimed
|
1 g
|
Powder For Injection (IV/IM)
|
Corticosteroid
|
VHB Medi Sciences Limited
|
India
|
Initial [Rx](Correction)
|
10 August 2022
|
30 March 2027
|
| View |
|
DR-XY47853
|
Cefazolin (as sodium)
|
Eozoline
|
1g
|
Powder for Solution (IM/IV)
|
Antibacterial (First Generation Cephalosprin)
|
NCPC Hebei Huamin Pharmaceutical Company Limited
|
China
|
Initial
|
30 March 2022
|
30 March 2027
|
| View |
|
DR-XY47854
|
Iron + Folic acid
|
Raricap Forte
|
50 mg (equivalent to 605 mg Ferrous calcium citrate) /
300 mcg
|
Film-Coated Tablet
|
Hematinic
|
Bafna Pharmaceuticals, Ltd
|
India
|
Initial
|
30 March 2022
|
30 March 2025
|
| View |
|
DR-XY47856
|
Daclastavir (As dihydrochloride)
|
Dacihep 30
|
30 mg
|
Film Coated Tablet
|
Antiviral for treatment of Hepatits C Virus (HCV) Infection
|
Cadila Healthcare Limited
|
India
|
Monitored Release
|
31 March 2022
|
31 March 2027
|
| View |
|
DR-XY47857
|
Daclastavir Dihydrochloride
|
Dacihep 30
|
30 mg
|
Film Coated Tablet
|
Antiviral for treatment of Hepatits C Virus (HCV) Infection
|
Cadila Healthcare Limited
|
India
|
Monitored Release
|
31 March 2022
|
31 March 2027
|
| View |
|
DR-XY47858
|
Daclastavir (As dihydrochloride)
|
Dacihep 60
|
60 mg
|
Film Coated Tablet
|
Antiviral for treatment of Hepatits C Virus (HCV) Infection
|
Cadila Healthcare Limited
|
India
|
Monitored Release
|
31 March 2022
|
31 March 2027
|
| View |
|
DR-XY47859
|
Clotrimazole
|
Candigo
|
100 mg/g (10% w/w)
|
Vaginal Cream
|
Anti-Infective and Antiseptic (Imidazole derivative)
|
Kusum Healthcare Pvt. Ltd.
|
India
|
Monitored Release
|
30 March 2022
|
30 March 2027
|
| View |
|
DR-XY47861
|
Ceftazidime (as pentahydrate)
|
Sitidime
|
1g
|
Powder for Injection (IM/IV)
|
-
|
Zhuhai Kinhoo Pharmaceutical Co. Ltd.
|
China
|
-
|
31 March 2022
|
31 March 2027
|
| View |
|
DR-XY47862
|
Citicoline
|
Nervcedil
|
250 mg/mL (1 g/4 mL)
|
Solution for Injection (IV/IM)
|
Other Psychostimulants and Nootropics
|
Scott-Edil Pharmacia Limited
|
India
|
Initial
|
31 March 2022
|
31 March 2027
|